1. RARE DISEASE COMMUNITIES
A EURORDIS PROJECT: TOWARD AN ONLINE PATIENT COMMUNITY
PORTAL FOR RARE DISEASES
Christel Nourissier
General Secretary, EURORDIS
2. The idea:
2
An online social network for patients & carers living
with Rare Disease to enable sharing of
experiences and access to quality information.
3. What this is not:
3
A patient association website.
A purely information website on a disease or
treatment.
A disease awareness website.
Just another forum.
4. What this is:
4
A Community for a group of people living with a
rare disease.
A place to share experiences on Quality of life &
Social issues using new online tools
Goals
Patient 2 Patient / Care 2 Carer Practical Support
Patient’s learn to trust their experience: Empowerment
Participate in growing knowledge: Scientific Progress
Sourcing better information & expertise: Literacy
Invite consultation with external experts: Relationship
Building
5. The role of the patient
5
organisation:
Improved visibility for patient organisation.
Display Logo & contact details
Link to association’s own website
Play a role in communicating to the community.
Dedicated blog written by patient organisation
Information
Research news
Policy developments
Events
Play a role in governance of the community.
Recruiting Moderators & Volunteers
6. The tools (part 1):
6
A Community homepage
Display latest activity in the community
Information pages written by experts & patients
Based on aggregate knowledge in forums & blogs
Forums
Classified sharing (moderated), public or private
Mailing-List
Private email list (moderated)
Testimonies
Share stories in photo, video or text
7. The tools (part 2):
7
Social Network
Make friends based on shared interests
Blog
An internet diary to document living with a disease (natural
history)
RSS Feeds
A “pipeline” for importing quality information
Bookmarks
Share your most commonly visited websites with others
13. Basic principals
13
Guaranteed by EURORDIS & NORD
Website hosting and security
Maintenance and long-term development
Support staff
Governance (linked to patient organisations and patients)
Each community built in consultation with patients
Pilot phase with 4 disease communities: launch Nov 09
Financed by European Commission, the French Telethon
(AFM) and the French Federation of Pharmaceuticals
(LEEM).
14. Benefits of a multi-community portal?
14
Patients are already sharing online via Facebook etc.
Limited in its potential for the advancement of
knowledge.
Moderators will read all exchanges and write synthesis articles
A portal guaranteed by EURORDIS & NORD protects
the voice of patients from purely commercial interests.
Negotiate the best kind of partnerships with research,
technology partners etc to effect maximum benefit for
greatest number of patients.
Stop re-inventing the wheel. Concentrate efforts.
15. EURORDIS’ experience
15
Mailing Lists for Rare diseases
Started in 2005
25 diseases in 2008
870 subscribers
Research trip to USA
Meetings with leaders such as PatientsLikeMe.com, WebMD.com,
American Cancer Society
Annual EURORDIS Conference – May 2009
Invited participation of successful models: duchenneconnect.org
Partnership with data-mining technology: bridge with research
Lessons Learned
Each community is different, therefore demands individual treatment
when building an online community.
EURORDIS Charter of Good Practice in Online Community governance.
16. Soliciting patient participation
16
Communication Based Assessment
Interviews with patients to determine where patients already
source their information (what websites, Journals etc..)
What are the subjects & themes that the community needs to talk
about i.e. a kind of table of contents?
What design, look-feel, colors would promote adoption &
adhesion?
Recruitment and follow-up support
Recruitment and training of a team of patient or carer volunteers
Administrator
Information manager
Host(s)
Moderators x 3 or4 (forums mailing-lists)
17. Participation of patients II
17
Test the community
Making sure it lives up to expectation before releasing
to all patients
Launch (Nov. 2009)
PHASE 1: Create start-up content to launch discussions
PHASE 2: Communicate to larger community of patients
to promote participation.